Cumberland Cash Per Share from 2010 to 2024

CPIX Stock  USD 1.48  0.03  2.07%   
Cumberland Pharmaceuticals Cash Per Share yearly trend continues to be fairly stable with very little volatility. Cash Per Share will likely drop to 1.22 in 2024. During the period from 2010 to 2024, Cumberland Pharmaceuticals Cash Per Share regression line of annual values had r-squared of  0.28 and arithmetic mean of  2.32. View All Fundamentals
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
1.2813423
Current Value
1.22
Quarterly Volatility
0.97995217
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 701.3 K or Selling General Administrative of 8.9 M, as well as many exotic indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or PTB Ratio of 0.82. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Cumberland Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Cumberland Pharmaceuticals Technical models . Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Latest Cumberland Pharmaceuticals' Cash Per Share Growth Pattern

Below is the plot of the Cash Per Share of Cumberland Pharmaceuticals over the last few years. It is Cumberland Pharmaceuticals' Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cumberland Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.24 X10 Years Trend
Slightly volatile
   Cash Per Share   
       Timeline  

Cumberland Cash Per Share Regression Statistics

Arithmetic Mean2.32
Geometric Mean2.08
Coefficient Of Variation42.32
Mean Deviation0.87
Median2.33
Standard Deviation0.98
Sample Variance0.96
Range3.0478
R-Value(0.53)
Mean Square Error0.74
R-Squared0.28
Significance0.04
Slope(0.12)
Total Sum of Squares13.44

Cumberland Cash Per Share History

2024 1.22
2023 1.28
2022 1.36
2021 1.81
2020 1.63
2019 1.83
2018 2.33

About Cumberland Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Cumberland Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Cumberland Pharmaceuticals investors use historical funamental indicators, such as Cumberland Pharmaceuticals's Cash Per Share, to determine how well the company is positioned to perform in the future. Although Cumberland Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Cumberland Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cumberland Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cumberland Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Per Share 1.28  1.22 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Cumberland Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cumberland Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cumberland Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cumberland Pharmaceuticals Stock:
Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Cumberland Stock analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is Cumberland Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cumberland Pharmaceuticals. If investors know Cumberland will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cumberland Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.59)
Revenue Per Share
2.728
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.05)
Return On Equity
(0.27)
The market value of Cumberland Pharmaceuticals is measured differently than its book value, which is the value of Cumberland that is recorded on the company's balance sheet. Investors also form their own opinion of Cumberland Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cumberland Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cumberland Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cumberland Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cumberland Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cumberland Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cumberland Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.